Kannaway Announces Record-Breaking Month for Japan Division

Medical Marijuana, Inc. announced that the Japanese division of its subsidiary Kannaway had record sales in February 2021, the best sales month in company history.

“When we first entered the Japanese market in late 2019, we were one of the first companies offering cannabidiol (CBD) products in the country and saw a great opportunity to give consumers the high-quality products they had been asking for,” said Kannaway® CEO Blake Schroeder. “Since then, our team has done tremendous work expanding our reach and footprint in Japan.”

Asia-Pacific is expected to be one of the fastest-growing regions in the CBD oil market, and Kannaway expects the Japanese CBD market to continue its rapid expansion.

“While leading our team in Japan, I have seen the positive response to our offerings in the country first-hand,” said Kannaway® Japan Division General Manager Peter Dale. “Our team has shown what can be done with hard work and a distinguishing product offering and I look forward to our further growth.”